Log inStart free trialBook a demo
Log inStart free trial
Media Database
>
Mark Leiser

Mark Leiser

Author at healio.com at Healio

Contact this person
Email address
m*****@*******.comGet email address
Influence score
26
Location
United States
Languages
  • English
Covering topics

    View more media outlets and journalists by signing up to Prowly

    View latest data and reach out all from one place
    Sign up for free

    Recent Articles

    healio.com

    Potential ‘new paradigm’: COVID-19 mRNA vaccines boost response to cancer immunotherapy

    The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value in personalized vaccines.The prevailing theory has been that a therapy tailored to each patient’s unique genomic profile — and designed to instruct the body to activate an immune response to cancer-specific proteins — offers the greatest chance for success.
    about 2 months ago
    healio.com

    ‘Surprisingly’ few Americans aware of link between alcohol consumpt...

    Despite increasing scientific evidence and warnings from public health advocates about the impact of alcohol consumption on cancer risk, public awareness and knowledge of the link remains low.Nearly two-thirds of U.S. adults either do not believe or do not know that drinking alcohol increases cancer risk, results of a cross-sectional survey study showed.
    about 2 months ago
    healio.com

    Trastuzumab deruxtecan a potential new standard for high-risk HER2-...

    There may be a new standard of care for patients with early HER2-positive breast cancer at high risk for recurrence after neoadjuvant therapy, according to study results presented at ESMO Congress.Fam-trastuzumab deruxtecan-nxki (Enhertu; Daiichi-Sankyo, AstraZeneca) improved invasive DFS by 53% compared with ado-trastuzumab emtansine (Kadcyla, Genentech) among patients with residual invasive
    2 months ago
    healio.com

    Allogeneic cell therapies offer ‘transformative potential’ to treat...

    Samer A. Srour, MB ChB, MS, has long hoped the remarkable success of chimeric antigen receptor therapy for treatment of hematologic malignancies could be replicated in other cancer types.“There is a tremendous need for this in solid tumors but progress has been slow,” Srour, associate professor in the department of stem cell transplantation and cellular therapy at The University
    2 months ago
    healio.com

    Cincinnati Children’s again named best hospital for pediatric cancer

    Cincinnati Children’s has retained its distinction as the No. 1 children’s hospital for cancer in the country.
    3 months ago
    healio.com

    Medical imaging radiation may cause 1 in 10 blood cancers among chi...

    One in 10 hematologic cancers among children and adolescents may be attributable to radiation exposure from medical imaging, according to study results.
    3 months ago
    healio.com

    ‘Punch in the gut’: AMA leads effort for physician exemption from H...

    The federal government’s plan to charge a $100,000 application fee for visas used by specialized foreign workers could have devasting consequences for health care delivery unless physicians are exempt, the AMA president told Healio.“We have a physician shortage — it is projected to exceed 80,000 in the next decade — and international medical graduates are one critical
    3 months ago
    healio.com

    ‘We have to go for it’: CAR-T’s success in glioblastoma prompts cal...

    The seven chimeric antigen receptor T-cell therapies approved in the United States have revolutionized treatment of blood cancers. Eight years after the first CAR-T product entered the market, members of the oncology community are expressing more confidence than ever that the wait for the first solid tumor indication may be nearing its end.
    3 months ago
    healio.com

    Machine learning model predicts urgent care visits during lung canc...

    Machine learning models can help predict which patients receiving systemic therapy for non-small lung cancer are most likely to need urgent care visits, according to study results.Models that incorporated patient-reported outcomes and data from wearable sensors significantly outperformed models trained on demographic and clinical data alone.
    3 months ago
    healio.com

    ‘More informed strategy’ needed to train hem/onc fellows who seek c...

    More structured and targeted professional development pathways are needed to ensure hematology/oncology fellows who wish to pursue careers in community-based settings receive appropriate training, according to study findings.A majority of U.S.-based hem/onc fellowship programs provide clinical training relevant to community-based careers but the type and extent varies, a national survey of
    3 months ago
    healio.com

    ‘Not doing enough’: Study reveals gaps in cancer survivors’ access ...

    Sociodemographic factors may influence cancer survivors’ ability to access pharmacologic treatment for mental health conditions, according to study results.Use of medication for depression or anxiety varied significantly based on race and ethnicity, as well as insurance status.
    4 months ago